Latest News for: vrtx
Edit
VRTX JPM 2026 Presentation vFINAL (Vertex Pharmaceuticals Incorporated)
Public Technologies 12 Jan 2026
Edit
Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why
The Call 06 Jan 2026
What Happened?. Shares of biotech company Vertex Pharmaceuticals (NASDAQ. VRTX) jumped 3.8% in the afternoon session after Wolfe Research upgraded the stock from "Peer Perform" to "Outperform" and issued a $548 price target ... More News. View More ... .
Edit
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today
The Call 03 Dec 2025
What Happened?. Shares of biotech company Vertex Pharmaceuticals (NASDAQ. VRTX) jumped 6.2% in the afternoon session after Morgan Stanley upgraded its rating on the stock to "Overweight" from "Equal-Weight" and increased its price target ... More News ... .
Edit
VRTX ASN Event Presentation 2025 Final (Vertex Pharmaceuticals Incorporated)
Public Technologies 09 Nov 2025
... Commission (SEC) and available through the company's website at https.//www.vrtx.com and on the SEC's website at https.//www.sec.gov ... AA VRTX Priority Review Voucher ensures 6-month FDA review.
Edit
Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Q3 In Line With Expectations
The Call 03 Nov 2025
VRTX) met Wall Streets revenue expectations in Q3 CY2025, with sales up 11% year on year to $3.08 billion ... Vertex Pharmaceuticals (VRTX) Q3 CY2025 Highlights. ... VRTX) develops and markets transformative ...
Edit
Vertex Pharmaceuticals (VRTX) Q3 Earnings: What To Expect
The Call 02 Nov 2025
Biotech company Vertex Pharmaceuticals (NASDAQ. VRTX) will be announcing earnings results this Monday after market hours. Here’s what you need to know ... Adjusted earnings are expected to come in at $4.58 per share ... More News. View More ... Via MarketBeat ... .
- 1